CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 105 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,091 | +2.3% | 21,358 | -9.1% | 0.06% | +5.1% |
| Q2 2023 | $99,816 | +51.6% | 23,486 | +89.4% | 0.06% | +63.9% |
| Q1 2023 | $65,839 | -38.9% | 12,399 | -27.8% | 0.04% | -35.7% |
| Q4 2022 | $107,796 | -49.9% | 17,165 | -15.7% | 0.06% | -34.9% |
| Q3 2022 | $215,000 | +95.5% | 20,369 | +0.8% | 0.09% | +109.8% |
| Q2 2022 | $110,000 | +27.9% | 20,215 | +115.2% | 0.04% | +7.9% |
| Q1 2022 | $86,000 | -42.7% | 9,392 | -5.6% | 0.04% | -33.3% |
| Q4 2021 | $150,000 | – | 9,949 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 474,067 | $2,266,040 | 15.18% |
| Elmwood Wealth Management, Inc. | 2,364,415 | $11,301,904 | 5.45% |
| PFM Health Sciences, LP | 6,724,715 | $32,144,138 | 1.51% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 892,786 | $4,267,517 | 1.29% |
| Avidity Partners Management LP | 6,050,212 | $28,920,013 | 1.16% |
| Paradigm Biocapital Advisors LP | 2,944,513 | $14,074,772 | 0.96% |
| Kynam Capital Management, LP | 1,068,527 | $5,107,559 | 0.84% |
| Green Alpha Advisors, LLC | 110,524 | $528,305 | 0.41% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,500,000 | $16,730,000 | 0.37% |
| Bruce & Co., Inc. | 200,000 | $956,000 | 0.33% |